GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cencora Inc (BSP:C1CO34) » Definitions » Forward PE Ratio

Cencora (BSP:C1CO34) Forward PE Ratio

: 17.78 (As of Today)
View and export this data going back to 2020. Start your Free Trial

Cencora's Forward PE Ratio for today is 17.78.

Cencora's PE Ratio without NRI for today is 20.58.

Cencora's PE Ratio for today is 25.80.


Cencora Forward PE Ratio Historical Data

The historical data trend for Cencora's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cencora Annual Data
Trend 2020-12 2021-12 2022-12 2023-12 2024-04
Forward PE Ratio
11.95 12.08 14.43 15.60 17.99

Cencora Quarterly Data
2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 6.13 5.74 11.95 14.01 11.89 11.60 12.08 14.71 12.69 11.96 14.43 13.12 14.68 13.97 15.60 18.62

Competitive Comparison

For the Medical Distribution subindustry, Cencora's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cencora Forward PE Ratio Distribution

For the Medical Distribution industry and Healthcare sector, Cencora's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Cencora's Forward PE Ratio falls into.



Cencora Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Cencora  (BSP:C1CO34) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Cencora Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Cencora's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cencora (BSP:C1CO34) Business Description

Traded in Other Exchanges
Address
1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

Cencora (BSP:C1CO34) Headlines

No Headlines